Xiubao Ren

CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells

Akihiro Tsuyada, Amy Yin Man Chow, Jun Wu et al. · Cancer Research · 2012 · 406 citations

Medicine, Cell Biology, Oncology +17

A novel MDSC-induced PD-1 ⁻ PD-L1 ⁺ B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties

Meng Shen, Jian Wang, Wenwen Yu et al. · OncoImmunology · 2017 · 96 citations · Full text

Medicine, Immunology, Oncology +17

Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · Journal of Thoracic Oncology · 2023 · 69 citations · Full text

Medicine, Oncology, Pharmacology +11

Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)

Xiaobin Shang, Gang Zhao, Fei Liang et al. · Annals of Translational Medicine · 2022 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17

Over-Expression of Semaphorin4D, Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor Is Related to Poor Prognosis in Ovarian Epithelial Cancer

Ying Chen, Lei Zhang, Yi Pan et al. · International Journal of Molecular Sciences · 2012 · 49 citations · Full text

Medicine, Cancer Biology, Oncology +12